152 related articles for article (PubMed ID: 38167862)
21. SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions.
Takahashi R; Nakatsukasa H; Shiozawa S; Yoshimura A
J Immunol; 2017 Jul; 199(1):149-158. PubMed ID: 28550203
[TBL] [Abstract][Full Text] [Related]
22. Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.
Ma H; Lu C; Ziegler J; Liu A; Sepulveda A; Okada H; Lentzsch S; Mapara MY
J Clin Invest; 2011 Jul; 121(7):2554-69. PubMed ID: 21670504
[TBL] [Abstract][Full Text] [Related]
23. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
24. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
25. Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells.
Venigalla RK; Guttikonda PJ; Eckstein V; Ho AD; Sertel S; Lorenz HM; Tretter T
J Autoimmun; 2012 Dec; 39(4):377-87. PubMed ID: 22824211
[TBL] [Abstract][Full Text] [Related]
26. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.
Wei J; Duramad O; Perng OA; Reiner SL; Liu YJ; Qin FX
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18169-74. PubMed ID: 17978190
[TBL] [Abstract][Full Text] [Related]
27. Age-Related Differences in Percentages of Regulatory and Effector T Lymphocytes and Their Subsets in Healthy Individuals and Characteristic STAT1/STAT5 Signalling Response in Helper T Lymphocytes.
Holcar M; Goropevšek A; Ihan A; Avčin T
J Immunol Res; 2015; 2015():352934. PubMed ID: 26525134
[TBL] [Abstract][Full Text] [Related]
28. Treg plasticity and human diseases.
Zhang Z; Guo J; Jia R
Inflamm Res; 2023 Dec; 72(12):2181-2197. PubMed ID: 37878023
[TBL] [Abstract][Full Text] [Related]
29. Tbet Expression by Regulatory T Cells Is Needed to Protect against Th1-Mediated Immunopathology during
Warunek J; Jin RM; Blair SJ; Garis M; Marzullo B; Wohlfert EA
Immunohorizons; 2021 Dec; 5(12):931-943. PubMed ID: 34893511
[No Abstract] [Full Text] [Related]
30. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
31. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2.
Koch MA; Thomas KR; Perdue NR; Smigiel KS; Srivastava S; Campbell DJ
Immunity; 2012 Sep; 37(3):501-10. PubMed ID: 22960221
[TBL] [Abstract][Full Text] [Related]
32. Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RA
Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
J Interferon Cytokine Res; 2017 Jun; 37(6):254-268. PubMed ID: 28256939
[TBL] [Abstract][Full Text] [Related]
33. IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.
Skartsis N; Peng Y; Ferreira LMR; Nguyen V; Ronin E; Muller YD; Vincenti F; Tang Q
Front Immunol; 2021; 12():783282. PubMed ID: 35003100
[TBL] [Abstract][Full Text] [Related]
34. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
35. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
36. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
37. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.
Kidani Y; Nogami W; Yasumizu Y; Kawashima A; Tanaka A; Sonoda Y; Tona Y; Nashiki K; Matsumoto R; Hagiwara M; Osaki M; Dohi K; Kanazawa T; Ueyama A; Yoshikawa M; Yoshida T; Matsumoto M; Hojo K; Shinonome S; Yoshida H; Hirata M; Haruna M; Nakamura Y; Motooka D; Okuzaki D; Sugiyama Y; Kinoshita M; Okuno T; Kato T; Hatano K; Uemura M; Imamura R; Yokoi K; Tanemura A; Shintani Y; Kimura T; Nonomura N; Wada H; Mori M; Doki Y; Ohkura N; Sakaguchi S
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35140181
[TBL] [Abstract][Full Text] [Related]
38. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
39. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe AE; Vignali DAA
Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
[TBL] [Abstract][Full Text] [Related]
40. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation.
Kobbe R; Kolster M; Fuchs S; Schulze-Sturm U; Jenderny J; Kochhan L; Staab J; Tolosa E; Grimbacher B; Meyer T
Gene; 2016 Jul; 586(2):234-8. PubMed ID: 27063510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
